STATEMENT OF PURPOSE
RS28987 / S1216
This is an FY 2022 additional appropriation bill for the Office of Drug Policy and includes $1,600,000 from the
Federal COVID-19 Relief Fund. It includes federal funds made available through the Coronavirus Response
and Relief Supplement Appropriations Act. This bill provides funding for primary prevention services as part
of the Substance Abuse Prevention and Treatment Block Grant awarded to the Idaho Department of Health and
Welfare. The additional funding to the block grant requires 20% be set aside for prevention services, which is
reflected in the $1,600,000 of this bill.
FISCAL NOTE
This bill provides an additional appropriation of $1,600,000 in onetime funding from the Federal COVID-19
Relief Fund to the Office of Drug Policy for FY 2022.
Contact:
Janet E Jessup
Budget and Policy Analysis
(208) 334-4730
DISCLAIMER: This statement of purpose and fiscal note are a mere attachment to this bill and prepared by a proponent
of the bill. It is neither intended as an expression of legislative intent nor intended for any use outside of the legislative
process, including judicial review (Joint Rule 18).
Statement of Purpose / Fiscal Note Bill SOP/FN INTRODUCED: 05/04/2021, 1:03 PM